Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 703065
                    [Title] => Novartis remains committed  to providing affordable drugs
                    [Summary] => 
 Novartis Healthcare Philippines will continue to work with government, Filipino health care professionals and its private sector partners to improve Filipino patients’ access to effective, affordable medicine through innovative access and research and development initiatives.
                    [DatePublished] => 2011-07-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 632717
                    [Title] => Novartis cited anew as most admired pharma firm
                    [Summary] => 
For the second consecutive year, readers of the respected industry publication Med Ad News have voted Novartis as the Most Admired Pharmaceutical Company for 2010.
                    [DatePublished] => 2010-11-25 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 556404
                    [Title] => Novartis drug pipeline voted industry's 'most innovative'
                    [Summary] => 
With 87 new drugs or vaccines under development and a leading focus on therapies that address rare diseases, research-based Swiss healthcare company Novartis has been selected by the pharmaceutical business and marketing news magazine Med Ad News as having the industry’s most innovative drug pipeline. 
                    [DatePublished] => 2010-03-11 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

OPPENS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 703065
                    [Title] => Novartis remains committed  to providing affordable drugs
                    [Summary] => 
 Novartis Healthcare Philippines will continue to work with government, Filipino health care professionals and its private sector partners to improve Filipino patients’ access to effective, affordable medicine through innovative access and research and development initiatives.
                    [DatePublished] => 2011-07-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 632717
                    [Title] => Novartis cited anew as most admired pharma firm
                    [Summary] => 
For the second consecutive year, readers of the respected industry publication Med Ad News have voted Novartis as the Most Admired Pharmaceutical Company for 2010.
                    [DatePublished] => 2010-11-25 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 556404
                    [Title] => Novartis drug pipeline voted industry's 'most innovative'
                    [Summary] => 
With 87 new drugs or vaccines under development and a leading focus on therapies that address rare diseases, research-based Swiss healthcare company Novartis has been selected by the pharmaceutical business and marketing news magazine Med Ad News as having the industry’s most innovative drug pipeline. 
                    [DatePublished] => 2010-03-11 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Novartis remains committed to providing affordable drugs

July 7, 2011 - 12:00am

 Novartis Healthcare Philippines will continue to work with government, Filipino health care professionals and its private sector partners to improve Filipino patients’ access to effective, affordable...

Science and Environment

Novartis cited anew as most admired pharma firm

November 25, 2010 - 12:00am

For the second consecutive year, readers of the respected industry publication Med Ad News have voted Novartis as the Most Admired Pharmaceutical Company for 2010.

Science and Environment

Novartis drug pipeline voted industry's 'most innovative'

March 11, 2010 - 12:00am

With 87 new drugs or vaccines under development and a leading focus on therapies that address rare diseases, research-based Swiss healthcare company Novartis has been selected by the pharmaceutical business and marketing...

Science and Environment